{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-303183","form_type":"8-K","ticker":null,"cik":"0001466301","company_name":"Clovis Oncology, Inc.","filed_at":"2022-12-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.750051+00:00","generated_at":"2026-06-21T05:18:47.103301+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Clovis Oncology to be delisted from Nasdaq on Dec 21 after Chapter 11 filing; shares to trade OTC under CLVSQ","bullets":["Received delisting notice from Nasdaq on Dec 12, 2022 due to Chapter 11 bankruptcy petitions filed Dec 11.","Trading suspension effective at open on Dec 21; company will not appeal the determination.","Common stock expected to trade OTC beginning Dec 21 under symbol CLVSQ.","Nasdaq cited inability to sustain compliance and public interest concerns as grounds for delisting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-303183","json":"https://secwatch.observer/filing/0001193125-22-303183.json","markdown":"https://secwatch.observer/filing/0001193125-22-303183.md","text":"https://secwatch.observer/filing/0001193125-22-303183.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1466301/000119312522303183/0001193125-22-303183-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1466301/000119312522303183/d425649d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T05:18:47.103301+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a5b11f2aea4461601ba0847882c8c4079a9cdaa5","claim":"Clovis Oncology, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).","evidence_excerpt":"December 12, 2022, the Company received written notice (the “ Delisting Notice ”) from the staff of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that, as a result of the Bankruptcy Petitions and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, the staff of Nasdaq had determined that the Company’s common stock (the “ Securities ”) will be delisted from Nasdaq. In the Delisting Notice, the staff of Nasdaq referenced concerns about the Company’s ability to sustain compliance with all requirements for continued listing on Nasdaq and public interest concerns re","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1466301/000119312522303183/0001193125-22-303183-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Rules","value":"5101, 5110(b), IM-5101-1"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}